The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Evidence for a Complex Influence of Nicotinic Acetylcholine Receptors on Hippocampal Serotonin Release
Abstract
The effects of nicotine on 5-hydroxytryptamine (5-HT) release from serotonergic nerve endings in rat dorsal hippocampal slices were studied. Nicotine (50-500 microM:) caused a concentration-dependent increase in 5-HT release. This effect was antagonised by mecamylamine (0.5 microM:), indicating an action at nicotinic receptors. Nicotine-evoked 5-HT release was not affected by tetrodotoxin (3 microM:), cadmium chloride (0.1 mM:), or the absence of Ca(2+) or Na(+) in the superfusion medium. Unexpectedly, higher concentrations of mecamylamine alone (1-50 microM:) increased 5-HT release. This suggested the presence of inhibitory input to 5-HT neurones and that these inhibitory neurones possess tonically active nicotinic receptors. The effect of mecamylamine (50 microM:) on 5-HT release was reduced by the muscarinic M(1) receptor agonist, McN-A-343 (100 microM:), but pirenzepine (0.005-1 microM:), which blocks M(1) receptors, alone increased 5-HT release. Hippocampal serotonergic neurones are known to possess both excitatory nicotinic receptors and inhibitory M(1) receptors. Although there may be several explanations for our results, one possible explanation is that nicotine stimulates 5-HT release by activating nicotinic heteroreceptors on 5-HT terminals. Mecamylamine (0.5 microM:) antagonises this effect, but higher concentrations increase 5-HT release indirectly by blocking the action of endogenous acetylcholine on nicotinic receptors situated on cholinergic neurones that provide muscarinic inhibitory input to 5-HT neurones.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both nicotine and the nicotinic antagonist mecamylamine can increase serotonin release in the hippocampus (Kenny et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Kenny et al., 2000
In the citing paper
“both chronic nicotine and the nicotinic antagonist mecamylamine can facilitate serotonin transmission in the hippocampus, while the effects of monoamine depletion can be partially reversed by nicotine administration and can lead to changes in anxiety-like behavior in the elevated plus maze (File et al., 2000a; File et al., 2000b; Fu et al., 1998; Kenny et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Kenny et al., 2000
Citations
Cites
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Human neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 417
Neuronal Nicotinic Acetylcholine Receptors
Lindstrom, J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-1775-1_10 · Cited by 382
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350
Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., & Albuquerque, E. X. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02693.1999 · Cited by 332
Alkondon, M., Pereira, E. F. R., Barbosa, C. T. F., & Albuquerque, E. X. (1997) · PubMed · Cited by 326
Chapter 11 Cell types using glutamate as a neurotransmitter in the vertebrate retina
Massey, S. C. (1990) · Progress in Retinal Research · doi:10.1016/0278-4327(90)90013-8 · Cited by 287
Research works printed but not linked: 1
- Ridley D.L., 1997, The influence of nicotine on 5‐HT overflow in the dorsal hippocampus of the rat., Br. J. Pharmacol., 122, 192P
Cited by
Sorted by citations
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 460
Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease
Wilkinson, D. G., Francis, P. T., Schwam, E. M., & Payne-Parrish, J. (2004) · Drugs & Aging · doi:10.2165/00002512-200421070-00004 · Cited by 367
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310
Self-citationNicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 285
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Dulawa, S. C., & Janowsky, D. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0219-x · Cited by 187
Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
Martorana, A., Esposito, Z., & Koch, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00175.x · Cited by 174
Kenny, P. J., File, S. E., & Rattray, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00246-1 · Cited by 165
Self-citationPicciotto, M. R., Lewis, A. S., van Schalkwyk, G. I., & Mineur, Y. S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.028 · Cited by 157
Nicotinic–serotonergic interactions in brain and behaviour
Seth, P., Cheeta, S., Tucci, S., & File, S. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00715-8 · Cited by 145
Self-citationDesensitization of nicotinic acetylcholine receptors as a strategy for drug development
Buccafusco, J. J., Beach, J. W., & Terry, A. V. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145292 · Cited by 144
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Self-citationCaldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 124
Christensen, R., Marcussen, A. B., Wörtwein, G., Knudsen, G. M., & Aznar, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.009 · Cited by 110
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Self-citationAndreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101
Lechín, F., van der Dijs, B., & Hernández-Adrián, G. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.025 · Cited by 101
Bacher, I., Wu, B., Shytle, D. R., & George, T. P. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903329102 · Cited by 96
Jamal, M., van der Does, W. A. J., Elzinga, B. M., Molendijk, M. L., & Penninx, B. W. J. H. (2014) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntu151 · Cited by 86
Andreasen, J. T., & Redrobe, J. P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c713e · Cited by 82
Popik, P., Kozela, E., & Krawczyk, M. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705359 · Cited by 74
Kulak, J. M., McIntosh, J. M., Yoshikami, D., & Olivera, B. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00357.x · Cited by 73
Rao, T. S., Correa, L. D., Adams, P. B., Santori, E. M., & Sacaan, A. I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03532-7 · Cited by 71
Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus
Kenny, P. J., File, S. E., & Rattray, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01501.x · Cited by 63
Self-citationNeurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats
Collins, S. L., Wade, D., Ledon, J., & Izenwasser, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.039 · Cited by 62
Tucci, S. A., Genn, R. F., & File, S. E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00391-x · Cited by 59
Self-citationRole of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
Aboul‐Fotouh, S. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3745-5 · Cited by 53
Biological basis for the co-morbidity between smoking and mood disorders
Mineur, Y. S., & Picciotto, M. R. (2009) · Journal of Dual Diagnosis · doi:10.1080/15504260902869964 · Cited by 51
Prefrontal neuromodulation by nicotinic receptors for cognitive processes
Coura, R., & Granon, S. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2596-6 · Cited by 57
Cheeta, S., Kenny, P. J., & File, S. E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00246.x · Cited by 50
Self-citationDecreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47
Andreasen, J. T., & Redrobe, J. P. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.016 · Cited by 47
Viveros, M., Marco, E. M., Llorente, R., & Lamota, L. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28fb4 · Cited by 44
Andreasen, J. T., Redrobe, J. P., & Nielsen, E. Ø. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.11.004 · Cited by 43
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats
Levin, E. D., Slade, S. K., Johnson, M., Petro, A. E., Horton, K., Williams, P., Rezvani, A. H., & Rose, J. E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.016 · Cited by 43
Effects of acute and chronic nicotine on elevated plus maze in mice: Involvement of calcium channels
Biała, G., & Budzyńska, B. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.043 · Cited by 47
Siegel, J. A., Craytor, M. J., & Raber, J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e44 · Cited by 43
Andreasen, J. T., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., Peters, D., Mirza, N. R., & Redrobe, J. P. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364271 · Cited by 38
Gould, R. W., Czoty, P. W., Nader, S. H., & Nader, M. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185538 · Cited by 37
Mineur, Y. S., Einstein, E. B., Bentham, M. P., Wigestrand, M. B., Blakeman, S., Newbold, S. A., & Picciotto, M. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.269 · Cited by 34
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64005-6 · Cited by 32
Section I. The Cholinergic System
Smythies, J. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)64001-9 · Cited by 32
α7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum
Aznar, S., Kostova, V., Christiansen, S. H., & Knudsen, G. M. (2005) · Synapse · doi:10.1002/syn.20108 · Cited by 31
Nicotine augmentation for refractory obsessive-compulsive disorder. A case report
Pasquini, M., Garavini, A., & Biondi, M. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.011 · Cited by 31
Smoking, parent smoking, depressed mood, and suicidal ideation in teens
Hockenberry, J. M., Timmons, E. J., & Weg, M. W. V. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp199 · Cited by 29
Wang, S., Yabuki, Y., Matsuo, K., Xu, J., Izumi, H., Sakimura, K., Saito, T., Saido, T. C., & Fukunaga, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206986 · Cited by 26
Dietary Restriction and Nicotine can Reduce Anxiety in Female Rats
Genn, R. F., Tucci, S. A., Edwards, J. E., & File, S. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300168 · Cited by 27
Self-citationRoni, M. A., & Rahman, S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.006 · Cited by 24
Fernandez, F., Aguerre, S., Mormède, P., & Chaouloff, F. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02110.x · Cited by 22
Development of tolerance to nicotine’s anxiogenic effect in the social interaction test
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)01984-9 · Cited by 22
Self-citationAndreasen, J. T., Nielsen, E. Ø., & Redrobe, J. P. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1560-1 · Cited by 21
Bhatti, A. S., Aydin, C., Oztan, O., Ma, Z., Hall, P., Tao, R., & Isgor, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1366-6 · Cited by 21
Nicotinic mechanisms contribute to soman-induced symptoms and lethality
Hassel, B. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.01.007 · Cited by 21
Hansen, C. P., Jensen, A. A., Christensen, J. K., Balle, T., Liljefors, T., & Frølund, B. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701625v · Cited by 21
Roni, M. A., & Rahman, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.009 · Cited by 22
Nasehi, M., Mohammadi-Mahdiabadi-Hasani, M.-H., Ebrahimi-Ghiri, M., & Zarrindast, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05294-0 · Cited by 18
Martínez-Ortega, J. M., Goldstein, B. I., Gutiérrez-Rojas, L., Sala, R., Wang, S., & Blanco, C. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.012 · Cited by 17
Rorabaugh, B. R., Sprague, L., Norman, H., Seeley, S. L., & D’Souza, M. S. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14100 · Cited by 16
Alpha-7 and alpha-4 nicotinic receptor subunit immunoreactivity in genioglossus muscle motoneurons
Dehkordi, O., Millis, R. M., Dennis, G. C., Coleman, B. R., Johnson, S. M., Changizi, L., & Trouth, C. O. (2005) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2004.09.003 · Cited by 16
Wang, T., Moon, J., Wu, Y., Amos, C. I., Hung, R. J., Tardón, A., Andrew, A. S., Chen, C., Christiani, D. C., Albanes, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185660 · Cited by 17
O'Connor, S. M., Sleebs, B. E., Street, I. P., Flynn, B. L., Baell, J. B., Coles, C., Quazi, N., Paul, D., Poiraud, E., Huyard, B., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109836 · Cited by 15
Functional Connectivity of the Raphe Nuclei: Link to Tobacco Withdrawal in Smokers
Faulkner, P., Ghahremani, D. G., Tyndale, R. F., Hellemann, G., & London, E. D. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy054 · Cited by 15
Hamurtekin, E., Bağdaş, D., & Gurun, M. S. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.058 · Cited by 14
Carrier-mediated release of monoamines induced by the nicotinic acetylcholine receptor agonist DMPP
Szász, B. K., MAYER, A., Zsilla, G., Lendvai, B., Vizi, E. S., & Kiss, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.023 · Cited by 13
Age-dependent effects of initial exposure to nicotine on serotonin neurons
Bang, S. J., & Commons, K. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.032 · Cited by 12
Kolisnyk, B., Al‐Onaizi, M., Prado, V. F., & Prado, M. A. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13260 · Cited by 12
Kumari, A., Sreetama, S. C., & Mohanakumar, K. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.027 · Cited by 11
Wooters, T. E., & Bardo, M. T. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1487-6 · Cited by 11
Kornum, B. R., Weikop, P., Møller, A., Rønn, L. C. B., Knudsen, G. M., & Aznar, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.030 · Cited by 11
Temporal sequencing of nicotine dependence and major depressive disorder: A U.S. national study
Martínez-Ortega, J. M., Franco, S., Rodríguez-Fernández, J. M., Gutiérrez-Rojas, L., Wang, S., & Gurpegui, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.087 · Cited by 9
Khadrawy, Y. A., El-Shamy, K. A., & Mohamed, S. (2011) · PubMed · Cited by 9
Nirogi, R. V. S., Abraham, R., Jayarajan, P., Goura, V., Kallepalli, R., Medapati, R. B., Tadiparthi, J., Goyal, V., Pandey, S. K., Subramanian, R., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06108-6 · Cited by 8
Role of Central Serotonin Receptors in Nicotine Addiction
Pierucci, M., Chambers, S., Partridge, L., Deurwaerdère, P. D., & Giovanni, G. D. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_14 · Cited by 8
Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic review
Piacentino, D., Maraone, A., Roselli, V., Berardelli, I., Biondi, M., Kotzalidis, G. D., & Pasquini, M. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00309-z · Cited by 8
Ma, Z., Pearson, E. J., Isgor, C., & Tao, R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.080 · Cited by 8
Severino, M., Pedersen, A. F., Trajkovska, V., Christensen, E. M., Lohals, R., Veng, L., Knudsen, G. M., & Aznar, S. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.026 · Cited by 7
Rivastigmine Restores 5-HT1A Receptor Levels in the Hippocampus of Olfactory Bulbectomized Mice
Islam, M. R., Moriguchi, S., Tagashira, H., & Fukunaga, K. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33012 · Cited by 6
Yu, J. (2010) · The Open Behavioral Science Journal · doi:10.2174/1874230001004010009 · Cited by 6
The Etiology and Treatment of Nicotine Dependence: A Biopsychosocial Perspective
Cohen, L. M., McChargue, D. E., Cortez-Garland, M., Prensky, E. H., & Emery, S. K. (2003) · Sage eBooks · doi:10.4135/9781412976770.n7 · Cited by 6
Mechanisms of stimulatory effects of mecamylamine on the dorsal raphe neurons
Hernández-González, O., Mondragón-García, A., Hernández‐López, S., Castillo-Rolón, D., Arenas-López, G., Tapia, D., & Mihailescu, S. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.031 · Cited by 5
Soria-Fregozo, C., Flores-Soto, M. E., Vega, M. I. P., & Feria‐Velasco, A. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.04.012 · Cited by 5
Hansen, C. P., Jensen, A. A., Balle, T., Bitsch-Jensen, K., Hassan, M. M., Liljefors, T., & Frølund, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.011 · Cited by 4
Soria-Fregozo, C., Flores-Soto, M. E., Vega, M. I. P., & Feria‐Velasco, A. (2012) · Neurología · doi:10.1016/j.nrl.2012.04.002 · Cited by 4
Blockade of cholinergic transmission elicits somatic signs in nicotine-naïve adolescent rats
Schmidt, C. E., Manbeck, K. E., Shelley, D., & Harris, A. C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00239 · Cited by 4
Khakpai, F., & Zarrindast, M. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-017 · Cited by 4
(2016) · Neurotransmitter · doi:10.14800/nt.1293 · Cited by 4
Harris, A. C. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173185 · Cited by 3
Central cholinergic transmission affects the compulsive-like behavior of mice in marble-burying test
Patel, C., Patel, R., Maturkar, V., & Jain, N. S. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148713 · Cited by 2
Cadmium Increases the Sensitivity of Adolescent Female Mice to Nicotine-Related Behavioral Deficits
Adeniyi, P. A., Olatunji, B. P., Ishola, A. O., Ajonijebu, D. C., & Ogundele, O. M. (2014) · Behavioural Neurology · doi:10.1155/2014/360978 · Cited by 2
Kim, E. A., Jung, K. C., Sohn, U. D., & Im, C. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.1.55 · Cited by 1
The Cannabinoid System in Nicotine Dependence and Withdrawal
McIlwain, M., Minassian, A., & Perry, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00009-0 · Cited by 1
Effect of Smoking Index on Cardiovascular System in Some Libyans
(2017) · ARC Journal of Forensic Science · doi:10.20431/2456-0049.0201002
남성 우울증 환자에서 흡연 유무에 따른 Loudness Dependence of the Auditory Evoked Potential의 차이
양은경, 김진환, & Lee, S. H. (2011) · 대한정신약물학회지
Millar, A. (2007) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2007-08375
Faulkner, P., Knudsen, G. M., Frøkjær, V. G., & Erritzøe, D. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf026
Metadata
- Authors
- Kenny, P. J., File, S. E., & Neal, M. J.
- Affiliations
- King's College London (GB)
- ORCID
- Kenny, Paul J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 75
- Issue
- 6
- Pages
- 2409-2414
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2029619668
- Cited by
- 100
- References
- 48
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, serotonin release, hippocampus, mecamylamine, M1 muscarinic receptor, McN-A-343, pirenzepine, serotonergic neurons, cholinergic modulation, inhibitory interneurons, nicotine
- MeSH terms
- Animals, Calcium, Calcium Channel Blockers, Carrier Proteins, Dose-Response Relationship, Drug, Hippocampus, Male, Mecamylamine, Membrane Glycoproteins, Nerve Tissue Proteins, Nicotine, Rats, Inbred Strains, Receptors, GABA-A, Receptors, Muscarinic, Receptors, Nicotinic, Serotonin, Tetrodotoxin, Selective Serotonin Reuptake Inhibitors, Paroxetine, Receptors, Glutamate, Nicotinic Agonists, Nicotinic Antagonists, Membrane Transport Proteins, Receptor, Muscarinic M1, Serotonin Plasma Membrane Transport Proteins, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review